NO151748C - Fremgangsmaate for fremstilling av en farmasoeytisk akseptabel, ikke-solvatert, vannfri, gamma-krystallinsk form av natriim-7-(d-alfa-formyloksy-alfa-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl-3-cefem-4-karboksylat - Google Patents

Fremgangsmaate for fremstilling av en farmasoeytisk akseptabel, ikke-solvatert, vannfri, gamma-krystallinsk form av natriim-7-(d-alfa-formyloksy-alfa-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl-3-cefem-4-karboksylat

Info

Publication number
NO151748C
NO151748C NO761017A NO761017A NO151748C NO 151748 C NO151748 C NO 151748C NO 761017 A NO761017 A NO 761017A NO 761017 A NO761017 A NO 761017A NO 151748 C NO151748 C NO 151748C
Authority
NO
Norway
Prior art keywords
methyl
alfa
sodrim
phenylacetamido
cephem
Prior art date
Application number
NO761017A
Other languages
English (en)
Other versions
NO761017L (no
NO151748B (no
Inventor
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO761017L publication Critical patent/NO761017L/no
Publication of NO151748B publication Critical patent/NO151748B/no
Publication of NO151748C publication Critical patent/NO151748C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO761017A 1975-04-11 1976-03-23 Fremgangsmaate for fremstilling av en farmasoeytisk akseptabel, ikke-solvatert, vannfri, gamma-krystallinsk form av natriim-7-(d-alfa-formyloksy-alfa-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl-3-cefem-4-karboksylat NO151748C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/567,324 US4006138A (en) 1975-04-11 1975-04-11 Crystalline form of sodium O-formylcefamandole

Publications (3)

Publication Number Publication Date
NO761017L NO761017L (no) 1976-10-12
NO151748B NO151748B (no) 1985-02-18
NO151748C true NO151748C (no) 1985-06-05

Family

ID=24266692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO761017A NO151748C (no) 1975-04-11 1976-03-23 Fremgangsmaate for fremstilling av en farmasoeytisk akseptabel, ikke-solvatert, vannfri, gamma-krystallinsk form av natriim-7-(d-alfa-formyloksy-alfa-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl-3-cefem-4-karboksylat

Country Status (31)

Country Link
US (1) US4006138A (no)
JP (1) JPS51123812A (no)
AR (1) AR210880A1 (no)
AT (1) AT343806B (no)
AU (1) AU500013B2 (no)
BE (1) BE840179A (no)
CA (1) CA1045114A (no)
CH (1) CH621554A5 (no)
CS (1) CS191970B2 (no)
DD (1) DD125950A5 (no)
DE (1) DE2614669C2 (no)
DK (1) DK148022C (no)
ES (1) ES446907A1 (no)
FI (1) FI65069C (no)
FR (1) FR2306698A1 (no)
GB (1) GB1546898A (no)
GR (1) GR59912B (no)
HU (1) HU175592B (no)
IL (1) IL49100A (no)
LU (1) LU74740A1 (no)
MX (1) MX3687E (no)
NL (1) NL184258C (no)
NO (1) NO151748C (no)
OA (1) OA05290A (no)
PL (1) PL104803B1 (no)
PT (1) PT64917B (no)
RO (1) RO68501A (no)
SE (1) SE435290B (no)
SU (1) SU668608A3 (no)
YU (1) YU40643B (no)
ZA (1) ZA761103B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7503274L (sv) * 1974-04-11 1975-10-13 Ciba Geigy Ag Cefalosporin
US4085277A (en) * 1975-01-30 1978-04-18 Fujisawa Pharmaceutical Co., Ltd. 7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
FR2400519A1 (fr) * 1977-08-17 1979-03-16 Roussel Uclaf Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
EP0432297A1 (en) * 1989-12-13 1991-06-19 Technologitschen Kombinat Sa Promischlena Mikrobiologia A method for the preparation of the sodium salt of O-formyl cefamandole
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
CN104530086B (zh) * 2014-12-16 2015-12-09 天津大学 头孢孟多酯钠化合物的新晶型及其结晶制备方法
CN105037392A (zh) * 2015-08-13 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种杀菌药物头孢孟多酯钠化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887551A (en) * 1964-11-04 1975-06-03 Glaxo Lab Ltd Crystalline forms of cephaloridine
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
PT64917B (en) 1977-08-24
PL104803B1 (pl) 1979-09-29
ZA761103B (en) 1977-10-26
CA1045114A (en) 1978-12-26
FR2306698B1 (no) 1979-10-05
CS191970B2 (en) 1979-07-31
JPS6110474B2 (no) 1986-03-29
SU668608A3 (ru) 1979-06-15
AR210880A1 (es) 1977-09-30
DE2614669C2 (de) 1984-09-27
JPS51123812A (en) 1976-10-28
AU1143576A (en) 1977-09-01
NO761017L (no) 1976-10-12
NL184258B (nl) 1989-01-02
YU79276A (en) 1982-10-31
IL49100A (en) 1979-03-12
YU40643B (en) 1986-04-30
FI65069B (fi) 1983-11-30
AT343806B (de) 1978-06-26
SE7602565L (sv) 1976-10-12
HU175592B (hu) 1980-09-28
IL49100A0 (en) 1976-04-30
DK148022B (da) 1985-02-04
GR59912B (en) 1978-03-20
ATA258476A (de) 1977-10-15
FI65069C (fi) 1984-03-12
PT64917A (en) 1976-04-01
FI760788A (no) 1976-10-12
DD125950A5 (no) 1977-06-01
NL7603660A (nl) 1976-10-13
FR2306698A1 (fr) 1976-11-05
DK148022C (da) 1985-07-22
BE840179A (fr) 1976-09-30
OA05290A (fr) 1981-02-28
US4006138A (en) 1977-02-01
GB1546898A (en) 1979-05-31
CH621554A5 (no) 1981-02-13
SE435290B (sv) 1984-09-17
DK150676A (da) 1976-10-12
AU500013B2 (en) 1979-05-10
MX3687E (es) 1981-04-29
DE2614669A1 (de) 1976-10-21
NL184258C (nl) 1989-06-01
ES446907A1 (es) 1977-09-16
RO68501A (ro) 1981-04-30
NO151748B (no) 1985-02-18
LU74740A1 (no) 1976-11-11

Similar Documents

Publication Publication Date Title
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO151748C (no) Fremgangsmaate for fremstilling av en farmasoeytisk akseptabel, ikke-solvatert, vannfri, gamma-krystallinsk form av natriim-7-(d-alfa-formyloksy-alfa-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl-3-cefem-4-karboksylat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
PH16078A (en) 5-oxo-6-hydroxy-4,5-dihydro-1,2,5-triazin-3yl-thiomethyl substituted derivatives of cephalosporin
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE440080B (sv) Forfarande for framstellning av klavulansyraderivat
GR58273B (en) Pharmaceutical compounds of ferrocenium
SE7507481L (sv) Forfarande for framstellning av nya cefalosporinderivat.
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE414029B (sv) Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE7510833L (sv) Forfarande for framstellning av nya cefalosporinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat
SE430162B (sv) Nytt forfarande for framstellning av cefalosporinderivat
SE413243B (sv) Forfarande for framstellning av vissa angivna farmaceutiskt anvendbara aminoalkanol-derivat
SE421127B (sv) Ett nytt forfarande for framstellning av cefalosporin- och penicillinderivat
ZA742905B (en) Pharmaceutically useful sulfur containing heterocyclic derivatives
SE7608472L (sv) Forfarande for sanering av en stalbehallare
SE7512658L (sv) Forfarande for framstellning av penicillinderivat
SE434952B (sv) Forfarande for framstellning av nya cefalosporinderivat